EFFECTIVENESS OF ISONIAZID PREVENTIVE THERAPY ON INCIDENCE OF TUBERCULOSIS AMONG PEOPLE LIVING WITH HIV IN SOUTHERN MAHARASHTRA
-
Published:2022-11-01
Issue:
Volume:
Page:70-72
-
ISSN:
-
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
-
language:en
-
Short-container-title:ijsr
Author:
Doshi Yagnesh Dhiren1, Anita Basavaraj2
Affiliation:
1. Senior Resident, Department Of General Medicine, Government Medical College and Hospital, Miraj, Sangli, Maharashtra. 2. Professor And Head, Department Of General Medicine, Government Medical College and Hospital, Miraj, Sangli, Maharashtra.
Abstract
Tuberculosis being the foremost opportunistic infection associated with Human Immunodeciency Virus infection contributes to high morbidity
and mortality among HIV seropositive persons. As per World Health Organisation TB statistics for 2020, and the India TB Report 2021- The
incidence of TB cases including HIV in India was 193 per 100000 population, of which mortality was 32 per 100000 cases. Isoniazid Preventive
Therapy reduces the reactivation of latent Tuberculosis infection and reduces the risk of acquiring TB by 70-90% among HIV co-infected
individuals. WHO recommends use of ART and Isoniazid Preventive Therapy (IPT) combination to reduce the burden of TB among HIV infected
patients. Considering the benets of IPT in PLHIV patients, this study was conducted over a period of 2 years from January 2020 to December 2021
in patients attending ART OPD of a tertiary care hospital in southern Maharashtra. Methods A prospective observational study was conducted on
patients attending ART OPD along with General Medicine OPD at a tertiary care hospital from January 2020 to December 2021. A total of 1497
PLHIV patients were started on IPT during this period and followed up. Results 92.18% i.e. 1380 of 1497 patients completed 6 months of IPT with
remaining 7.82% i.e. 117 patients not able to complete the entire 6 months due to treatment related side effects, follow up difculties or mortality.
Of 1497 patients, only 2 patients (0.13%) developed Pulmonary Tuberculosis after initiation of IPT and the remaining didn't show any signs or
symptoms of tuberculosis on follow up. Conclusion Results of IPT in PLHIV were highly effective with only 0.13% i.e. 2 patients developing
Tuberculosis during the course of treatment with the remaining not having tuberculosis even on follow up or being reported till date. The results of
the study along with other studies conducted worldwide clearly indicate the effectiveness of IPT in PLHIV and thereby its implementation should
be further strengthened.
Publisher
World Wide Journals
Subject
Dentistry (miscellaneous),Complementary and alternative medicine,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous),Internal Medicine,General Dentistry,Information Systems,Theoretical Computer Science,Software,Computer Networks and Communications,Software,Artificial Intelligence,Computer Vision and Pattern Recognition,Software,Mechanics of Materials,Civil and Structural Engineering,Mechanics of Materials,Civil and Structural Engineering,Education
Reference19 articles.
1. Narayanan S, Swaminathan S, Supply P, Shanmugam S, Narendran G, Hari L, Ramachandran R, Locht C, Jawahar MS, Narayanan PR. 2010. Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis 201: 691–703. 2. World Health Organization. 2010b. Global Tuberculosis control: World Health Organization, Geneva: WHO press. 3. Golub, JE, Pronyk, P, Mohapi, L, Thsabangu, N, Moshabela, M, Struthers, H, Gray, GE, McIntyre, JA, Chaisson, RE and Martinson, NA. 2009. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort Journal of the International AIDS Society 23(5):631–636 4. https://www.who.int/news-room/fact-sheets/detail/tuberculosis. 5. World Health Organization. Global Tuberculosis Report. 2016.documents/s23098en/s23098en.pdf
|
|